final action
on 13 Nov 2024
Last Applicant/ Owned by
First Floor, Minerva House
Ballsbridge Dublin 4
IE
Serial Number
98516417 filed on 24th Apr 2024
Registration Number
N/A
Correspondent Address
Camille M. Miller
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Medical research in the fields of chemicals and pharmaceuticals; Scientific research and testing services in the fields of chemicals and pharmaceuticals; Research and development of new products for others in the fields of chemicals and pharmaceuticals; Development of pharmaceutical products to spec Read More
Providing medical information and online medical information on the subjects of pharmaceutical preparations and medicines, medical devices and techniques; Providing medical information and online medical and healthcare information to healthcare professionals and patients; Providing a website featuring medical information; Providing medication counseling information, namely, advice and data on the subjects of pharmaceutical preparations and medicine; Providing medical information on the subjects of aesthetic solutions to help patients feel better about their bodies; Patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient
N/A
N/A
Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Medical research in the fields of chemicals and pharmaceuticals; Scientific research and testing services in the fields of chemicals and pharmaceuticals; Research and development of new products for others in the fields of chemicals and pharmaceuticals; Development of pharmaceutical products to specifications of others; Research and development of pharmaceutical products for others
N/A
N/A
Educational services, namely, conducting classes, seminars, and workshops in the field of pharmaceutical preparations, medical devices and techniques; Educational services, namely, conducting classes, seminars, workshops and training for doctors, nurses and others in the fields of critical care, critical testing, maternal health, rare diseases and conditions, anesthesia, and aesthetic solutions to help patients feel better about their bodies
N/A
N/A
Medical devices for use in treating pelvic disorders; Medical devices for use in treating pelvic organ prolapse; Medical devices for use in treating urinary incontinence; Medical devices for use in pain management and alleviation; Medical devices, namely, surgical equipment in the fields of urology and men's health; Medical devices, namely, intrauterine devices; Injection syringes; Injection device for pharmaceuticals and medicine; medical devices for use in treating critical care, critical testing, maternal health, anesthesia, diseases, kidney disorders, cellulite, skin care, dermatological use, folds, scars, and body contouring
N/A
N/A
Custom manufacture of pharmaceutical products to order and specification of others; Providing technical information in the field of pharmaceutical manufacturing
N/A
N/A
Pharmaceutical and medical preparations in connection with critical care, critical testing, maternal health, anesthesia, diseases, kidney disorders, cellulite, skin care, dermatological use, folds, scars, and body contouring and for rejuvenating to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities and in doctor's offices; pharmaceutical preparations, namely, analgesics and pain management preparations, preparations for the treatment of cancers, preparations for the treatment of urological diseases and disorders, preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of preparations for the treatment of diseases and disorders of the endocrine system, hormone replacement therapy preparations; drug substances, namely, enzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; medicated gels and and mineral supplements; food supplements; radio frequency identification tagged pharmaceutical products, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators,vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents; pharmaceutical preparations for endocrinology, orthopedics, urology, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents; House mark for a line of pharmaceuticals for human use
N/A
N/A
Healthcare management services, namely, providing administrative support services to physicians and healthcare providers who prescribe pharmaceutical preparations; Business administration of patient reimbursement programs for pharmaceuticals; Business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient
N/A
N/A
No 98516417
No Service Mark
No 00597834
Yes
Yes
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
13th Nov 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
13th Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
13th Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
10th Nov 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
10th Nov 2024 | NON-FINAL ACTION E-MAILED |
10th Nov 2024 | NON-FINAL ACTION WRITTEN |
31st Oct 2024 | ASSIGNED TO EXAMINER |
13th Oct 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
26th Jul 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
26th Jul 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |